Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer (Q43128963)
Jump to navigation
Jump to search
scientific article published on 16 March 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer |
scientific article published on 16 March 2010 |
Statements
1 reference
Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer (English)
1 reference
Barbara Burtness
1 reference
Kyle E Rusthoven
1 reference
Steven J Feigenberg
1 reference
David Raben
1 reference
Madeleine Kane
1 reference
John I Song
1 reference
Nicos Nicolaou
1 reference
Ranee Mehra
1 reference
John Ridge
1 reference
Robyn Swing
1 reference
Miriam Lango
1 reference
Roger Cohen
1 reference
Antonio Jimeno
1 reference
Changhu Chen
1 reference
16 March 2010
1 reference
1 reference
78
1 reference
4
1 reference
1020-1025
1 reference
Identifiers
1 reference
1 reference